 |
|
Standard
| T/CHATA 041-2024 Regulation for the treatment of rifampicin-resistant tuberculosis (English Version) |
|
|
|
|
|
|
|
|
Detail of T/CHATA 041-2024
| Standard No. |
|
| English Name |
|
| Chinese Name |
|
| Chinese Classification |
|
| Professional Classification |
|
| ICS Classification |
|
| Issued by |
|
| Issued on |
|
| Implemented on |
|
| Status |
|
| Superseded by |
|
| Superseded on |
|
| Abolished on |
|
| Superseding |
|
| Language |
|
| File Format |
| Word Count |
| Price(USD) |
|
| Keywords |
|
Introduction of T/CHATA 041-2024
本文件规定了利福平耐药结核病长程治疗方案和短程治疗方案中抗结核药物、治疗方案制定原则、治疗方案调整原则、治疗期间监测、停止治疗指征和治疗转归分类。
本文件适用于各级疾病预防控制机构（结核病防治机构）、结核病定点医疗机构耐药结核病的规范化治疗方案制定和效果评价。
Contents of T/CHATA 041-2024